Retina Innovation Lab

Prof. Elad Moisseiev is the chairman of the ophthalmology department at Meir Medical Center. He is a full clinical professor of Ophthalmology at the Tel Aviv University, and is also the chairman of the Israeli Ophthalmology Society (IOS). He is a vitreoretinal and cataract surgeon, and is very active in research and teaching, with over 100 publications.

Professor and Head of Retina, Division of Ophthalmology, Vice President at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Grey Faculty of Medicine at Tel Aviv University.

Main field of interest is early detection and home monitoring for retinal disease, the investigation of drug administration and toxicity to the retina.

She has been leading several cutting-edge technologies implemented in large scale clinical trials and in clinical setting including the home OCT, a technology implementing virtual reality in vitreoretinal surgery to replace the standard operating microscope. She serves on advisory boards of most large current pharmaceutical companies.

Published more than 500 papers in peer reviewed journals and contributed multiple chapters to ophthalmology textbooks.

Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology, and of Ophthalmologica.

Has many additional national and international roles as a leader in the field of medicine and retinal disease: serves on the board of European Society of Retina Specialists (Euretina), is a member in the Academia Ophthalmological Internationalis, leads mentorship groups of ARVO, Euretina and programs sponsored by industry. In Israel, is a member of the national council of surgery, and a member of the Israeli Academy of medicine.

Is the recipient of several awards, including: Michelson Award of the Macula Society, The Macula Society Arnall Patz Medal, Pyron Award of ASRS, Jules Gonin Lecture of the Retina Research Foundation Award and Merit of the Retina Society Award.

Serves on the Board of NotalVision, Pulsenmore, Revenio companies as well as on the board of ESASO (European school for advanced studies in ophthalmology).

Dr. Orly Gal-Or is a Medical Retina Specialist and ophthalmologist specializing in retinal imaging and artificial intelligence (AI)-based diagnostics, with a focus on age-related macular degeneration (AMD) and retinal ageing. As Director of Retinal Imaging Services at Rabin Medical Center and faculty member at Tel Aviv University, she leads a multidisciplinary program bridging advanced ophthalmic imaging with deep learning to develop novel diagnostic and prognostic tools for ageing-related retinal diseases. Her international training — including a Medical Retina Fellowship at Vitreous-Retina-Macula Consultants of New York (VRMNY) under Prof. K. Bailey Freund and Prof. Lawrence Yannuzzi — has shaped a career centered on multimodal imaging innovation alongside clinical excellence. Over the past decade, Dr. Gal-Or has established an independent research group, secured competitive funding as Principal Investigator, and built an active program of student supervision and international collaboration. She is 10 years from specialist qualification (2016), at the early-to-mid career stage.

Dr. Lilach Zoller is the Director of Technology and Digital Health at Clalit, where she drives the medical technology and digital health strategy for Israel’s largest healthcare provider. She oversees the strategic evaluation and implementation of advanced solutions, including AI, big data, robotic surgery, imaging, and 3D visualization. Dr. Zoller holds an MD from the Technion, an MBA from Ono Academic College, and executive education from Harvard. Board-certified in Dermatology and Healthcare Management, she remains a practicing clinician.

Previously, she was Chief Medical Officer for Clalit’s Haifa and West Galilee District, managing care for 775,000 people and leading the district to top national quality benchmarks. Her executive experience includes serving as CMO for Maccabi Healthcare Services (Northern District) and as a medical command officer in the IDF.

Mr. Avi Danziger is the General Manager of Roche Pharmaceutials Israel.

Mr. Danziger joined Roche in 1989 and has served as the General Manager of Roche's pharmaceutical division in Israel since 2000.

Mr. Danziger holds a BSc in Biology from Ben-Gurion University, Israel, and a Business Management diploma from the Technion, Israel.

Avi Danziger previously served as the Chairman of Pharma Israel, the association of research-based pharmaceutical companies in Israel, as well as a board member.

Nadine Hollander is CEO of Lirot, the Israeli research association of eye health and blindness prevention, for the last 18 years.

She has an MA in educational research from Tel-Aviv University, and is member of the Retina International association, representing Israel.

The Lirot association was founded in 2006 with one main goal: to prevent blindness by promoting research and creating up-to-date, reliable knowledge for patients, especially for at-risk populations such as the elderly and children.

As Lirot's CEO, Nadine is very proud of a few projects she initiated and developed: the community eye health project and the annual eye health awareness campaign.

In 2013 she joined and helped promote the Israeli consortium for Retinal diseases research (recruiting patients all over Israel). This consortium published a nationwide genetic analysis of inherited retinal disease in Israel (2019), published in Human Mutations, Wiley.

Dr. Yuval Dror is a sociologist who has been researching the impact of technology on society for more than 30 years. He has held prominent roles in Israeli technology journalism, including technology and science reporter and editor at Haaretz, technology columnist for Yedioth Ahronoth, technology journalist for Channel 2 News, and editorial team member of Channel 10’s London and Kirshenbaum program.

Dr. Dror served as Dean of the School of media studies at the College of Management Academic Studies and has taught at leading Israeli universities. He also headed the Digital Transformation Program at Tel Aviv University’s Lahav Executive Education.

Dr. Dror is regarded as one of Israel’s leading voices on the business, social, cultural, and educational implications of the artificial intelligence revolution. He is the author of four books, including the bestseller Hidden Code. He hosted the popular podcast Osim Technologia for seven years, and currently hosts the podcast Perfect Storm.